相关实验视频

Updated: Mar 9, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

为什么健康的志愿者参与临床试验?

Thijs van Iersel¹, Jelle Klein², Timothy C Hardman³

¹ICON, Groningen, the Netherlands.

British journal of clinical pharmacology

|March 8, 2026

概括

在临床试验中,健康的志愿者优先考虑为新疗法做出贡献,而不是金钱补偿. 了解他们对舒适,社交互动和设施的需求对于伦理试验进行和志愿者保留至关重要.

科学领域:

临床研究是临床研究.
志愿者研究研究志愿者研究
参与者需要评估评估.

背景情况:

了解健康志愿者的动机是成功临床试验的关键.
以前的研究还没有完全阐明志愿者在参与试验期间的具体需求.

研究的目的:

调查健康志愿者参与临床试验的主要动机.
确定健康志愿者在临床研究单位逗留期间的基本需求和偏好.

主要方法:

欧洲药物开发研究联合会 (EUFEMED) 开发了一项由58个问题组成的调查.
该调查评估了动机,便利性,风险/益处感知,社会互动,伙伴关系和利他主义.
该调查对参与欧洲临床研究单位 (CRU) 的第一阶段试验的健康志愿者进行.

主要成果:

共有4349名健康的志愿者参与了调查.
贡献新疗法 (54%) 是主要的动机,其次是货币补偿 (41%).
主要的志愿者需求包括功能良好的淋浴 (89%),户外接入 (78%),美食质量 (76%),高速互联网 (73%),私人空间 (69%) 和良好的休息 (69%).
与工作人员 (85%) 的社交互动和舒适的环境 (70%) 被高度重视,与其他参与者 (63%) 交往.

结论:

健康的志愿者在临床试验期间有不同的舒适性和社交互动需求.
解决这些志愿者需求可以提高招聘,合规和留守.
对临床试验设计和进行的伦理,以主体为中心的方法得到了志愿者的偏好理解的支持.

关键词:

调查调查调查调查临床研究单位临床研究单位早期的临床发展.健康的志愿者中心性.他们的动机是动机.需要需要需要需要需要需要.

更多相关视频

Working with Human Tissues for Translational Cancer Research

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.